Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
Authors: Authors: Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E.
Bone Marrow Transplant
View full abstract on Pubmed
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Authors: Authors: Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E, Kadin M, Antin J.
Biol Blood Marrow Transplant
View full abstract on Pubmed
Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia.
Authors: Authors: Lehmann LE, Guinan EC, Halpern SL, Donovan MJ, Bierer BE, Parsons SK.
Bone Marrow Transplant
View full abstract on Pubmed
Treatment of chronic graft-versus-host disease with clofazimine.
Authors: Authors: Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH.
Blood
View full abstract on Pubmed
Competitive inhibition of calcineurin phosphatase activity by its autoinhibitory domain.
Authors: Authors: Sagoo JK, Fruman DA, Wesselborg S, Walsh CT, Bierer BE.
Biochem J
View full abstract on Pubmed
Differential phosphorylation of the T lymphocyte costimulatory receptor CD28. Activation-dependent changes and regulation by protein kinase C.
Authors: Authors: Hutchcroft JE, Tsai B, Bierer BE.
J Biol Chem
View full abstract on Pubmed
Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase.
Authors: Authors: Hutchcroft JE, Bierer BE.
J Immunol
View full abstract on Pubmed
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Authors: Authors: Fay JW, Wingard JR, Antin JH, Collins RH, Piñeiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ.
Blood
View full abstract on Pubmed
Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp).
Authors: Authors: Wesselborg S, Fruman DA, Sagoo JK, Bierer BE, Burakoff SJ.
J Biol Chem
View full abstract on Pubmed
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.
Authors: Authors: Yeh WC, Bierer BE, McKnight SL.
Proc Natl Acad Sci U S A
View full abstract on Pubmed